Celyad Oncology S.A (CYAD) | Stock Price History & Returns | 2013 - 2025

How has Celyad Oncology S.A (CYAD) stock performed during last 12 months?

Over the last 12 months, Celyad Oncology S.A has delivered a total return of 69.6%.

• 52-Week High reached EUR1.22 on November 7, 2024.
• 52-Week Low touched EUR0.21 on August 20, 2024.
• Current Price trading at EUR0.39 as of August 10, 2025.

What is Celyad Oncology S.A's (CYAD) total stock return over the past 5 years?

Over the past 5 years, investing EUR10,000.00 in Celyad Oncology S.A (cyad) would have grown to approximately EUR448.00 as of August 10, 2025, representing a total return of -95.5%.

This represents a compound annual growth rate (CAGR) of -46.3% over the 5-year period.

How does Celyad Oncology S.A's Stock 10-year annualized return compare to the Healthcare sector?

Celyad Oncology S.A (cyad) has delivered an annualized return of -38.4% over the past 10 years.

To illustrate: EUR10,000.00 invested in Celyad Oncology S.A would have grown to EUR79.00 over this 10-year period.

This performance should be compared against other companies in the Healthcare sector to understand relative performance.

What was Celyad Oncology S.A's best-performing year historically?

Celyad Oncology S.A (cyad) has achieved its strongest performance over the 12 months period, delivering a total return of 69.6%.

What is the longest period of consecutive yearly growth Celyad Oncology S.A has achieved historically?

Celyad Oncology S.A (cyad) shows the following performance across different time periods:

Positive Returns: 12 months (+69.6%)

Negative Returns: 3 years (-81.0%), 5 years (-95.5%), 10 years (-99.2%)

This represents mixed performance in delivering positive returns across different time horizons.

For more common questions about our data, please visit our About Data page.